Abstract. Colon cancer is the third most common cancer and one of the leading causes of cancer-related death in the world. Therefore, identification of biomarkers with potential in recognizing the biological characteristics is a key problem for early diagnosis of colon cancer patients. In this study, we used a random forest approach to discover biomarkers based on a set of oligonucleotide microarray data of colon cancer. Realtime PCR was used to validate the related expression levels of biomarkers selected by our approach. Furthermore, ROC curves were used to analyze the sensitivity and specificity of each biomarker in both training and test sample sets. Finally, we analyzed the clinical significance of each biomarker based on their differential expression. A single classifier consisting of 4 genes (IL8, WDR77, MYL9 and VIP) was selected by random forests with an average sensitivity and specificity of 83.75 and 76.15%. The differential expression levels of each biomarker was validated by real-time PCR in 48 test colon cancer samples compared to the matched normal tissues. Patients with high expression of IL8 and WDR77, and low expression of MYL9 and VIP had a significantly reduced median survival rate compared to colon cancer patients. The results indicate that our approach can be employed for biomarker identification based on microarray data. These 4 genes identified by our approach have the potential to act as clinical biomarkers for the early diagnosis of colon cancer.
Introduction
Colon cancer is the third most common cancer, and one of the leading causes of morbidity and mortality in the world (1) . According to the United States' statistics released in 2010 the incidence rate of colon has decreased (2) . Over the last decade, many studies have proposed various kinds of statistical methods to analyze gene expression patterns and identify new biomarkers for prognostic and/or predictive information in relation to human diseases (3, 4) . However, most of the early studies applied unsupervised approaches to data-mining and identification of differential gene expressed profiling of certain diseases, such as hierarchical clustering for class discovering, taking an unbiased approach to searching for subgroups in the data (5) . Along with the statistical methods extensively penetrated into the field of biomedicine, many supervised clustering analysis and machine learning approaches were adopted to deal with gene expression profiling data and sieved feature genes which contained more information to classify different kinds of diseases or subclasses of the same disease.
Various methods of statistics and machine learning, including clustering (6,7), Bayesian algorithms (8) , and support vector machines (9) , have been proposed to analyze microarray data generated through high-throughput experiments. Over the last few years, the technology of multiclassifier fusion developed substantially, and became very successful in improving the accuracy of certain classifiers. Random forests (RF) (10, 11) , a tree-based method of classification and regression, is one of the most important methods of multiclassifier fusion. Besides the outcome of classification, RF also returns several measures of variable importance according to which feature genes can be selected. Since RF is comparable with other methods and even better to a certain extent (12) , it is used broadly especially for microarray data (13) . Additionally, RF can be used as not only a supervised algorithm but also an unsupervised one (14) , which depends on whether the gene expression data come from known classes or not.
In this study, we adopted an RF-based method for feature gene selection incorporating deductive reasoning to process the differential gene expressed profiling of colon cancer. We thus, selected 4 feature genes (IL8, WDR77, MYL9 and VIP) for colon cancer classification. Then, the differential expression level of each biomarker was validated by real-time PCR and in 48 test colon cancer samples compared to their matched normal tissues with high sensitivity and specificity. The results showed that our approach could filter out genes of great importance based on microarray data, and the genes selected by our approach were validated with high accuracy in classifying colon cancer and matched normal samples. 
Materials and methods
Micoarray data set. In 1999, Alon, et al (15) detected the whole genome of 40 colon tumor and 22 normal samples using an Affymetrix oligonuleotide array (Hum6000) and a two-way clustering approach to classify genes into functional groups. The microarray data was downloaded at: http://genomicspubs.princeton.edu/oncology/affydata/index.html. To further study this group of microarray data and rediscover potential biomarkers not been mined completely, we used an RF-based machine learning method in our investigation.
RF algorithm. One of the most important supervised methods RF was used for data-mining in this study. The reliable measure is based on the decrease of classification accuracy when values of a variable in a node of a tree undergo random permutations (16) . All training set observations were assigned to different terminal nodes in a tree and distinct split values were determined through several criterions such as the Gini index. The class of majority of training set observation in the terminal node was selected as the class of the node. We selected fewer genes with which the classifiers produced smallest out-of-bag (OOB) errors and highest classification scores. For sample j, we defined mr j as the difference between its accuracy rate and misclassifying rate. Additionally, we defined the mean decrease of accuracy rate of gene g as MDA (g). The calculating formulas of mr j and MDA (g) are represented as follows:
I(g) denotes indicator function; ntree is the number of tree classifiers; N, total samples; OOB j (i) = T, represents that sample j exists in OOB data set for tree i. If j is correctly classified by i, V j (i) = Tclass. Similarly, j is correctly classified after the value of gene g is randomly permuted V j(g) (i) = Tclass.
RNA isolation and real-time-PCR.
A total of 48 colon cancer and matched normal tissues from Wuhan General Hospital of Guangzhou Command were used in this study for real-time-PCR experiment. Total RNA was extracted from the tissue samples according to a standard TRIzol protocol (Invitrogen, Carlsbad, CA, USA). Total RNA (5 µg) was reverse transcribed to cDNA with 200 U M-MLV reverse transcriptase (Promega, Madison) according to a standard manufacturer's protocol. The reverse transcription reaction conditions were: 37˚C for 60 min, 72˚C for 10 min. Real-time-PCR was performed in a total 20 µl reaction mixture with 2 µl of cDNA, 0.6 µl 20X EvaGreen (CapitalBio, Beijing, China), and 0.5 µl of each 10 µM forward and reverse primers, 0.5 µl of 2.5 mM dNTP, 1.5 U Cap Taq polymerase (CapitalBio), 10 µl of 2X PCR buffer for EvaGreen and 6.1 µl of ddH 2 O. Quantification of differentially expressed genes was conducted with an RT-Cycle™ 2.0 system (CapitalBio). Real-time-PCR was carried out with programmed parameters, heating at 9˚C for 5 min followed by 40 cycles of a 3-stage temperature profile of 95˚C for 30 sec, 57˚C for 30 sec, 72˚C for 30 sec. All reactions were designed with 3 duplications and the final Ct values were determined by the average Ct value of the duplicated reaction. The melting curves for each PCR reaction were carefully analyzed to avoid non-specific amplifications in PCR products. The expression of each gene was transformed using the 2 -ΔΔCt formula and normalized with the β-actin expression (17) . 
Results
Biomarker rediscovery by the RF approach. We processed the microarray data of colon cancer using an RF-based algorithm. According to the OOB error rate, we identified 4 genes as a classifier to classify colon cancer and normal samples, composed of two upregulated genes IL8 and WDR77, and two downregulated genes MYL9 and VIP (Tables Ⅰ and Ⅱ) . The classification accuracy of the 4-gene classifier was 91.94% (Fig. 1A) . The average expression levels of each gene and the clustering graphical overview are shown in Fig. 1B and C. (Table Ⅳ) . The expression levels of WDR77 were associated with the clinical stage (P= 0.008), 
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Characteristics (+) (n=37) (-) (n=11) P-value (+) (n=34) (-) (n=14) P-value (+) (n=13) (-) (n=35) P-value (+) (n=15) (-) (n=33) P-value numbers of the embolus (P= 0.035) and the survival time of the patients. On the contrary, negative expression of MYL9 and VIP were associated with median survival time of colon cancer patients (Table Ⅳ) . In addition, negative expression of VIP was associated with the differentiation status of cancer cell (P=0.026) and recurrence risk (P=0.019) of colon cancer patients (Table Ⅳ) . The details of clinical significance for all the candidate biomarkers are shown in Table Ⅳ .
Discussion
Colon cancer is one of the most common diseases in the world, but only few tumor-specific gene products have been identified that could serve as targets to aid in the diagnosis of colon cancer. Its high prevalence and bad prognosis encourage researchers to find new biomarkers for the diagnosis and treatment of colon cancer. The microarray technique provides an effective method to identify a large scale of candidate biomarkers. Gene expression, methylation and microRNA profiling of colon cancer have been performed (18) (19) (20) . High-throughput microarray technologies have generated a large amount of data, where, various statistical and machine learning methods were adopted to analyze the data for finding gene or protein expression patterns and search for new biomarkers of human diseases. Microarray data analysis involves selecting the biomarkers which contain useful information necessary for molecular classification of human diseases and for establishing a gene expression profile. In this study, we present a concise investigative mode for feature gene selecting. We used a supervised machine learning algorithm RF to select gene a classifier based on differential gene expression profiling. A series of biological experiments were used to validate the results from high-throughput data.
RF is an effective algorithm with classifying quality comparable to other methods such as support vector machines (SVM) (10) . It can also select featured genes which embody differentially expressed levels among different samples. We applied RF to deal with a colon cancer dataset and identified 4 genes which had great biological significance. The classifier composed of the 4 genes produced a high accuracy on both the training and the test samples. Bootstrap aggregating, a resam ple technique, is used when building the RF. This technique allows RF not to prune like other tree-based classification algorithm. Furthermore, RF can avoid over-fitting effectively although the mechanism is not currently clear. Besides dealing with the gene expression microarray data, RF has been extensively used in other aspects of biomedicine territory. In the latest years, RF was adopted extensively to analyze the single-nucleotide polymorphisms data (21) and the gene pathway building investigation (22) .
In order to identify biomarkers with high sensitivity and specificity, verification in the laboratory and detection of new test clinical samples are important. Real-time PCR and tissuemicroarray-based IHC staining provided us convenient and precise approaches to detect the expression levels of candidate biomarkers. Our results also showed that real-time PCR was sensitive and specific for gene expression level validation. The PCR-based detection method therefore, appears to provide us with an easy way in early clinical diagnosis of human cancer.
The function and clinical significance of IL8 and VIP have been reported. There are 1,182 studies describing the gene function of IL8, including the biological mechanism in progress of most kinds of human cancer such as: glioblastoma, gastric carcinoma, small cell lung cancer, prostate cancer, esophageal squamous cell carcinoma, acute myelogenous leukemia, and colon cancer (23) (24) (25) (26) (27) (28) (29) . It was confirmed that IL8 is differentially expressed in colon cancer, and is associated with proliferation, migration, angiogenesis and chemosensitivity in colon cancer cell line models (30) . The VIP gene has also been the focus of investigation in many studies ralating to human cancer (31) (32) (33) (34) (35) (36) . WDR77, also known as p44, was reported to be related to the differentiation and proliferation in prostate epithelium (37) . Its differential expression was observed in ovarian cancer (38) . However, there is no report associating WDR77 with colon cancer. Thus, WDR77 is a novel potential biomarker of colon cancer. Similarly to WDR77, MYL9 has not been well-documented as being functionally associated with human cancer, including colon cancer. Therefore we reconfirmed its expression levels both at the RNA and protein levels by PCR and IHC methods, respectively.
In summary, we used an RF-based method to process a differential gene expression profile of colon cancer and selected 4 featured genes as candidate biomarkers of colon cancer. We validated these biomarkers in clinical colon cancer samples by a real-time PCR method. Our results showed that this approach filtered out genes of great importance, like IL8 and VIP based on microarray data, also including some new genes as WDR77 and MYL9 with the potential to act as cancer-related biomarkers.
